Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Ocugen Inc (OCGN)

Ocugen Inc (OCGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 483,083
  • Shares Outstanding, K 215,662
  • Annual Sales, $ 0 K
  • Annual Income, $ -58,370 K
  • 60-Month Beta 4.59
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.39
Trade OCGN with:

Options Overview Details

View History
  • Implied Volatility 125.21% ( -0.86%)
  • Historical Volatility 101.45%
  • IV Percentile 28%
  • IV Rank 13.09%
  • IV High 298.29% on 11/02/21
  • IV Low 99.15% on 05/04/22
  • Put/Call Vol Ratio 0.13
  • Today's Volume 1,633
  • Volume Avg (30-Day) 3,375
  • Put/Call OI Ratio 0.26
  • Today's Open Interest 116,002
  • Open Int (30-Day) 116,279

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -0.07
  • Number of Estimates 2
  • High Estimate -0.07
  • Low Estimate -0.07
  • Prior Year -0.13
  • Growth Rate Est. (year over year) +46.15%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.67 +33.53%
on 05/12/22
2.73 -18.32%
on 04/21/22
-0.47 (-17.41%)
since 04/20/22
3-Month
1.67 +33.53%
on 05/12/22
4.53 -50.77%
on 02/22/22
-1.23 (-35.55%)
since 02/18/22
52-Week
1.67 +33.53%
on 05/12/22
17.65 -87.37%
on 11/03/21
-6.85 (-75.44%)
since 05/20/21

Most Recent Stories

More News
Is Ocugen Finally on the Way to Vaccine Revenue?

It's entering a new market -- one that has authorized its vaccine.

PFE : 52.47 (+3.59%)
OCGN : 2.23 (-0.45%)
Where Will Ocugen Be in 1 Year?

Can the company return to its 2021 highs?

OCGN : 2.23 (-0.45%)
Ocugen, Inc. (OCGN) Q1 2022 Earnings Call Transcript

OCGN earnings call for the period ending March 31, 2022.

OCGN : 2.23 (-0.45%)
Ocugen (OCGN) Reports Q1 Loss, Misses Revenue Estimates

Ocugen (OCGN) delivered earnings and revenue surprises of -280% and 100%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

OCGN : 2.23 (-0.45%)
ALIM : 5.01 (+8.21%)
Ocugen Provides Business Update and First Quarter 2022 Financial Results

Conference Call and Webcast Today at 8:30 a.m. ET OCU400 Phase 1/2 clinical trial for groundbreaking modifier gene therapy for the treatment of NR2E3...

OCGN : 2.23 (-0.45%)
Ocugen to Host Conference Call on Friday, May 6 at 8:30 a.m. ET to Provide Business Update and Discuss First Quarter 2022 Financial Results

MALVERN, Pa., May 02, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biotechnology company focused on discovering, developing and...

OCGN : 2.23 (-0.45%)
2 Small-Cap Stocks With Monster Upsides, According to Wall Street

Sometimes analysts are on the spot, and other times, not so much.

OCGN : 2.23 (-0.45%)
BTAI : 13.57 (+2.49%)
Ocugen, Inc. to Present Preclinical Results at The Association for Research in Vision and Ophthalmology (ARVO) 2022 Annual Meeting

MALVERN, Pa., April 29, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biotechnology company focused on discovering, developing and...

OCGN : 2.23 (-0.45%)
First Week of June 10th Options Trading For Ocugen (OCGN)

Investors in Ocugen Inc saw new options begin trading this week, for the June 10th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the OCGN options chain for the...

OCGN : 2.23 (-0.45%)
Is It Too Late to Buy Ocugen Stock?

Could the hype surrounding this once-popular meme stock return?

OCGN : 2.23 (-0.45%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Ocugen Inc. is a clinical stage biopharmaceutical company. It is focused on discovering, developing and commercializing therapies which address rare and underserved eye diseases. The company's product pipeline consists of OCU400, OCU300, OCU100 and OCU200 which are in clinical stage. Ocugen Inc., formerly...

See More

Key Turning Points

3rd Resistance Point 2.64
2nd Resistance Point 2.49
1st Resistance Point 2.36
Last Price 2.23
1st Support Level 2.07
2nd Support Level 1.92
3rd Support Level 1.79

See More

52-Week High 17.65
Fibonacci 61.8% 11.55
Fibonacci 50% 9.66
Fibonacci 38.2% 7.77
Last Price 2.23
52-Week Low 1.67

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar